This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Slovak coffee technology bid-rigging probe ends without antitrust findings

( August 22, 2025, 13:51 GMT | Official Statement) -- MLex Summary: A 2020 proceeding led by the Slovak competition authority — into whether four companies engaged in a cartel agreement as part of a public tender for the supply of roasted-coffee production technology and packaging — has been discontinued. The four companies were Din-Technik, Ergasia, PPS Gastro and Triapex. In 2023, the cartel was initially fined under the authority’s first-instance decision. But last year, the watchdog’s appeal body overturned that ruling and referred the case back to the cartel unit for reconsideration. Landis, the tender organizer, was then included in the scope of the probe on suspicion of manipulating the tender. With the deadline for imposing a fine having expired in November 2024, and with no grounds found for a competition-law breach, the office decided to close the proceeding.Statement follows (in Slovak). ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections